INJ Trades at $7.163 After Launch of New Institutional Gateway Could Not Be Confirmed
Key Facts
The launch of an Injective gateway called Institutional Rail, and the operational details attributed to it in the draft, could not be confirmed. EL7 data showed INJ closing at $7.163 on Nov. 2, compared with $7.185 the previous day. On its website, Injective describes institutional infrastructure that includes restricted gateways and dedicated compliance layers, and says its goal is to bring institutional capital onto the network. The official page also lists 3.00 billion on-chain transactions and more than 500 assets. It also shows $6.8 billion in real-world assets tokenized. These indicators put the network’s activity and institutional ambitions in a broader context, but do not confirm the gateway launch described in the draft.
Injective’s institutional solutions page outlines a model that can limit access to and interaction with a tokenized product to approved participants, with operations beginning in a restricted environment and the option to add participants and counterparties later. The company says its programmable compliance controls include identity verification and anti-money-laundering checks, sanctions screening, and transfer restrictions within tokenized assets. On Sept. 2, Injective described its Mint platform as an environment for institutions to issue and manage tokenized assets, with compliance controls built into every transaction. These materials point to an institutional direction in the company’s products, without mentioning an Institutional Rail gateway. They also do not confirm that transactions are routed directly to validators or that institutions receive priority in execution.
Injective announced on July 27 that POSCO International and LG CNS had selected its infrastructure for a live trial tokenizing trade receivables arising from actual transactions. On Sept. 24, the company launched the Meridian upgrade following a governance vote, according to a report by The Block. The report quoted Chief Executive Eric Chen as saying the upgrade aims to move institutional clients from experimentation to tokenizing assets, offering them and using them as on-chain collateral. On Oct. 20, Injective announced a partnership with BDACS to introduce KRW1, which it described as the first fully won-backed stablecoin, as a settlement asset for real-world asset and tokenization activities on the network. It then announced on Oct. 27 options on real-world indices and commodities, fully backed by native USDC on the network from the time the contract is created. These announcements show an expanding range of applications and assets aimed at institutions, while the alleged gateway launch remains unconfirmed.
On verifying the identities of participants operating the network, Injective said Four Pillars had become an institutional validator and that FP Validated manages this activity. The company said the validator is active on mainnet with a current commission of 5%. Separately, a filing with the U.S. Securities and Exchange Commission put the active validator set at 45 validators on Sept. 15, 2026. This information shows institutional validators within a defined-size set, but does not connect Four Pillars or any of the entities mentioned in the draft to an Institutional Rail gateway. Nor does it provide evidence of a change in transaction ordering or in how institutions access the network.
Injective Institutional Services’ registration as a transfer agent with the U.S. Securities and Exchange Commission was reported on Injective’s website in a news item dated Aug. 19, 2026. The registration applies to a subsidiary and does not in itself mean that the Injective network or its token has been approved, nor does it confirm the launch of a new gateway. EL7 previously covered the company’s transfer-agent registration on Aug. 19 and the launch of the Mint platform for institutional asset tokenization on July 22. In an interview cited by The Block, Chen said the license marked the start of work on additional U.S. licenses, adding: "There are a couple of other licenses that we're going to be going after." The report linked these efforts to the possibility of an institution on Injective acting as a clearinghouse for settlement. The article did not specify when the additional licenses might be obtained.
On U.S. exchange-traded funds linked to INJ, Chen told The Block that 2027 was "a little bit further away than it should be," suggesting that, in his view, a launch before that year appeared likely. The report cited filings from 21Shares, Canary and REX-Osprey. This information does not include an announcement of regulatory approval or a specific launch date. The token remained at $7.163 at the Nov. 2 close, versus $7.185 at the Nov. 1 close, according to EL7 data. The data provided did not explain the daily price move or link it to the tokenization and licensing news.